MedPath

Tufts University

Tufts University logo
🇺🇸United States
Ownership
Private
Established
1852-01-01
Employees
5K
Market Cap
-
Website
http://www.tufts.edu
upi.com
·

Sugary drinks tied to millions of diabetes, heart disease cases

A Tufts University study links sugar-sweetened beverage consumption to 2.2 million new type 2 diabetes and 1.2 million new heart disease cases annually worldwide. The research emphasizes the need for public health actions, including taxes and advertising regulations, to combat this preventable health crisis.
statnews.com
·

Save the Food and Drug Administration by breaking it up

The FDA operates as multiple entities focusing on drugs, devices, food, cosmetics, and tobacco, leading to public confusion. Proposing to split the FDA into two distinct agencies could improve focus and trust, preserving its role in drug safety and innovation while addressing food safety concerns separately.
forbes.com
·

Five Breakthroughs In 2024 That Laid A Foundation For Future Tech

Albert Einstein won the Nobel Prize for the photoelectric effect, not relativity. Innovations in 2024 include DNA computing advancements, a real-life Spider-Man web fluid, space-manufactured drugs, human spliceosome mapping, and coal-based EV battery components.
avma.org
·

Zoetis confers teaching, research awards for 2024

Winners of the 2024 Zoetis Distinguished Veterinary Teacher Award and Zoetis Award for Veterinary Research Excellence include educators and researchers from various universities, recognized for their teaching abilities, leadership, and innovative research advancing veterinary medicine.
cen.acs.org
·

The 'compuchem'-AI showdown

Schrödinger, a computational chemistry company, resists AI hype in drug discovery, emphasizing physics-based methods. CEO Ramy Farid highlights AI's limitations, using it selectively with curated datasets. Schrödinger's approach focuses on molecular interactions, differentiating it from AI-only methods. The company has a successful track record, including cofounded firms and an internal drug pipeline.
finance.yahoo.com
·

Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial

Enlivex Therapeutics approved for Phase I trial of Allocetra in TMJ osteoarthritis by Israeli Ministry of Health. Trial to assess tolerability, efficacy, and safety in six non-responsive subjects. Allocetra, a universal cell therapy, aims to reset macrophages and potentially treat critical illnesses.
webdisclosure.com
·

Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call

Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call on GLP-1 RA weight loss therapy-induced muscle loss, featuring experts like Professor Roger Fielding and moderated by Rob Van Maanen.
aacr.org
·

Frontiers in Cancer Science 2024 in Singapore

The 16th Frontiers in Cancer Science (FCS) conference will be held in Singapore from November 13-15, 2024, featuring international and regional speakers on topics like immuno-oncology, genomics, metabolism, and AI. Young investigators can present their work, with prizes including travel awards to the AACR Annual Meeting 2025. The conference is jointly organized by several Singaporean institutions and has partnered with the American Association for Cancer Research (AACR) since 2020.
news.cornell.edu
·

Silvia Formenti, Massimo Loda elected to National Academy of Medicine

Dr. Silvia Formenti and Dr. Massimo Loda, both chairs at Weill Cornell Medicine, were elected to the National Academy of Medicine for their significant contributions to advancing medical sciences. Formenti pioneered the combination of radiation therapy with immunotherapy, while Loda's work illuminated prostate cancer's metabolic mechanisms, leading to targeted treatments.
© Copyright 2025. All Rights Reserved by MedPath